Loading clinical trials...
Loading clinical trials...
A 12-month Double-blind, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Efficacy of Endoluminal Aluvra™ for the Treatment of Gastroesophageal Reflux Disease
Conditions
Interventions
Aluvra™
Saline
Locations
10
United States
Keck School of Medicine of USC
Los Angeles, California, United States
Digestive Health Center
Palo Alto, California, United States
SOFI - Center for Esophageal Wellness
Englewood, Colorado, United States
Mayo Clinic Florida
Jacksonville, Florida, United States
Esophageal Institute of Atlanta
Atlanta, Georgia, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Start Date
November 1, 2017
Primary Completion Date
July 1, 2021
Completion Date
July 1, 2022
Last Updated
March 12, 2020
NCT07310927
NCT06953986
NCT06241183
NCT05781347
NCT04360252
NCT04795934
Lead Sponsor
Impleo Medical Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions